Search - tctmd.com

Displaying 541 - 560 of 1012

Sort: Relevancy | Date

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Presentation TCT 2016

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Daniel Burkhoff

October 31, 2016

Presentation TCT 2016

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Michael Haude

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

Rationale for and Design of GALILEO

Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

Presentation TCT 2016

EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease

Presenter: Michael D. Dake, Michael R. Jaff, Sanjiv Lakhanpal

October 31, 2016

Presentation TCT 2016

Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower Extremity Superficial Venous Disease

Presenter: Michael D. Dake, Michael R. Jaff, Zvonimir Krajcer

October 31, 2016

Presentation TCT 2016

Latest Results on Catheter Assisted Thrombolysis and Thrombectomy for Submassive and Massive PE

Presenter: Michael D. Dake, Michael R. Jaff, Akhilesh K. Sista

October 31, 2016

Presentation TCT 2016

Featured Lecture: The Rationale and Impact of New European Device Regulations

Presenter: Michael J. Mack, Aaron V. Kaplan, Alan G. Fraser

October 31, 2016

Presentation TCT 2016

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Presenter: Michael D. Dake, Michael R. Jaff, Mark J. Goodwin, Constantino S. Pena

October 31, 2016

Presentation TCT 2016

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Presenter: Michael D. Dake, Michael R. Jaff, Mark J. Goodwin, Constantino S. Pena

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Presenter: Michael J. Lim, Payam Dehghani

October 31, 2016

Presentation TCT 2016

Catheter-Directed Thrombolysis and Pharmacomechanical Lysis for Acute DVT: Patient Selection and Outcomes

Presenter: Michael D. Dake, Michael R. Jaff, Mahmood K. Razavi

October 31, 2016

Presentation TCT 2016

State of the Art Lecture: Latest Medical Therapies for DVT and PE - What the Interventionist Must Know!

Presenter: Michael D. Dake, Michael R. Jaff

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Presenter: Michael J. Lim, Molly Szerlip

October 31, 2016

Presentation TCT 2016

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Presenter: Stephan Windecker, Michael Joner

October 31, 2016

Advertisement

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Rationale for and Design of GALILEO

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease

Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower Extremity Superficial Venous Disease

Latest Results on Catheter Assisted Thrombolysis and Thrombectomy for Submassive and Massive PE

Featured Lecture: The Rationale and Impact of New European Device Regulations

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Catheter-Directed Thrombolysis and Pharmacomechanical Lysis for Acute DVT: Patient Selection and Outcomes

State of the Art Lecture: Latest Medical Therapies for DVT and PE - What the Interventionist Must Know!

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content